Bachem Holding AGBCHMF 91 Interest Coverage is 364.04 as of Dec. 2025, which is 19% above its 10-year median of 306.89. GuruFocus rates BCHMF with a GF Score™ of 91/100 and a GF Value™ of $98.06 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 377 Biotechnology companies, Bachem Holding AG ranks better than 58.09% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Bachem Holding AG's
Operating Income
for the
six
months ended in Dec. 2025 was $126.0 Mil. Bachem Holding AG's Interest Expense for the
six
months ended in Dec. 2025 was $-0.3 Mil.
Bachem Holding AG's interest coverage for the quarter that ended in Dec. 2025 was 364.04.
The higher the ratio, the stronger the company's financial strength is.
Good Sign:
Bachem Holding AG has no debt.
The historical rank and industry rank for Bachem Holding AG's Interest Coverage or its related term are showing as below:
BCHMF'
s Interest Coverage Range Over the Past 10 Years
Min: 116.61 Med: 306.89 Max: 4173.55
Current: 420.36
BCHMF's Interest Coverage is ranked better than 58.09% of 377
companies
in the Biotechnology industry
Industry Median: 106.07
vs BCHMF: 420.36
Bachem Holding AG (OTCPK:BCHMF) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Bachem Holding AG Interest Coverage Related Terms
Bachem Holding AG Interest Coverage Historical Data
* Premium members only.
The historical data trend for Bachem Holding AG's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
BCHMF vs VRTX, REGN, ALNY: Interest Coverage Comparison
For the Biotechnology subindustry, Bachem Holding AG's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bachem Holding AG Interest Coverage vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Bachem Holding AG's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Bachem Holding AG's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bachem Holding AG (BCHMF) has a Interest Coverage of 364.04 as of Dec. 2025. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Bachem Holding AG and its competitors. This is 19% above median its historical median of 306.89. Over the past decade, Bachem Holding AG's Interest Coverage has ranged from 116.61 to 4,173.55. According to the industry distribution chart, Bachem Holding AG ranks #158 out of 377 companies in the Biotechnology industry, placing it in the top 41.9%.
Is Bachem Holding AG's Interest Coverage too high?
Bachem Holding AG's current Interest Coverage of 364.04 is 19% above median its 10-year median of 306.89. Over the past 10 years, this metric has ranged from a low of 116.61 to a high of 4,173.55. The Biotechnology industry median Interest Coverage is 106.07. Bachem Holding AG's value of 364.04 is 243.2% above this industry median. Based on the distribution chart, Bachem Holding AG ranks #158 out of 377 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Bachem Holding AG has a GF Score™ of 91/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bachem Holding AG's Interest Coverage compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Bachem Holding AG ranks #158 out of 377 companies for Interest Coverage. This puts Bachem Holding AG in the upper half of its industry. The industry median Interest Coverage is 106.07. Bachem Holding AG's value of 364.04 is 243.2% above this benchmark. Historically, Bachem Holding AG's own Interest Coverage has ranged from 116.61 to 4,173.55 over the past decade. While the company's 10-year median is 306.89 vs. the industry median of 106.07, Bachem Holding AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Biotechnology company?
The median Interest Coverage among Biotechnology companies is 106.07, based on 377 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bachem Holding AG's current Interest Coverage of 364.04 is 243.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Bachem Holding AG and its competitors. For the Biotechnology industry, the median Interest Coverage is 106.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bachem Holding AG's current Interest Coverage is 364.04, which is 19% above median its own 10-year median of 306.89. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bachem Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Bachem Holding AG (BCHMF) is currently considered Modestly Undervalued. The stock's GF Value™ is $98.06, compared to a current price of $87.34 — trading 10.9% below its estimated fair value. The current Interest Coverage is 364.04, which is 19% above median its 10-year median of 306.89 and 243.2% above the Biotechnology industry median of 106.07. Bachem Holding AG's overall GF Score™ is 91/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Bachem Holding AG (BCHMF), the current Interest Coverage is 364.04 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bachem Holding AG (BCHMF) Overvalued in 2026?
Based on GuruFocus' analysis, Bachem Holding AG stock appears to be undervalued.
The current stock price of $87.34 is trading 10.9% below its estimated GF Value™ of $98.06.
GuruFocus considers Bachem Holding AG to be Modestly Undervalued.
Key valuation signals for BCHMF:
Interest Coverage: 364.04 (19% above median its 10-year median of 306.89)
GF Value™: $98.06 vs. price of $87.34 (10.9% below fair value)
Industry Position: 243.2% above the Biotechnology median (#158 of 377)
No single metric tells the full story. See the BCHMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bachem Holding AG is a biochemical company that provides services to the pharmaceutical and biotechnology industry. It focuses on specializing in the development and manufacture of peptides and oligonucleotides. The group markets its products under the Bachem and Clinalfa brands. Its products and services are CMC Development, Commercial API, Research and Specialities, and Services and Capabilities. Geographically, it operates in Switzerland, USA, Ireland, Denmark, United Kingdom, and Rest of the World.
91GF Score
Get the complete analysis for BCHMF
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BCHMF has been successfully added to your 
